167 related articles for article (PubMed ID: 18790661)
1. Genetic variation of Omi/HtrA2 and Parkinson's disease.
Ross OA; Soto AI; Vilariño-Güell C; Heckman MG; Diehl NN; Hulihan MM; Aasly JO; Sando S; Gibson JM; Lynch T; Krygowska-Wajs A; Opala G; Barcikowska M; Czyzewski K; Uitti RJ; Wszolek ZK; Farrer MJ
Parkinsonism Relat Disord; 2008 Nov; 14(7):539-43. PubMed ID: 18790661
[TBL] [Abstract][Full Text] [Related]
2. A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease.
Krüger R; Sharma M; Riess O; Gasser T; Van Broeckhoven C; Theuns J; Aasly J; Annesi G; Bentivoglio AR; Brice A; Djarmati A; Elbaz A; Farrer M; Ferrarese C; Gibson JM; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Klein C; Lambert JC; Lesage S; Lin JJ; Lynch T; Mellick GD; de Nigris F; Opala G; Prigione A; Quattrone A; Ross OA; Satake W; Silburn PA; Tan EK; Toda T; Tomiyama H; Wirdefeldt K; Wszolek Z; Xiromerisiou G; Maraganore DM;
Neurobiol Aging; 2011 Mar; 32(3):548.e9-18. PubMed ID: 20036034
[TBL] [Abstract][Full Text] [Related]
3. Genetic variations of Omi/HTRA2 in Chinese patients with Parkinson's disease.
Wang CY; Xu Q; Weng L; Zhang Q; Zhang HN; Guo JF; Tan LM; Tang JG; Yan XX; Tang BS
Brain Res; 2011 Apr; 1385():293-7. PubMed ID: 21338583
[TBL] [Abstract][Full Text] [Related]
4. HtrA2/Omi is involved in 6-OHDA-induced endoplasmic reticulum stress in SH-SY5Y cells.
Luo F; Wei L; Sun C; Chen X; Wang T; Li Y; Liu Z; Chen Z; Xu P
J Mol Neurosci; 2012 May; 47(1):120-7. PubMed ID: 22246992
[TBL] [Abstract][Full Text] [Related]
5. Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's disease.
Westerlund M; Behbahani H; Gellhaar S; Forsell C; Belin AC; Anvret A; Zettergren A; Nissbrandt H; Lind C; Sydow O; Graff C; Olson L; Ankarcrona M; Galter D
FASEB J; 2011 Apr; 25(4):1345-52. PubMed ID: 21163861
[TBL] [Abstract][Full Text] [Related]
6. Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls.
Simón-Sánchez J; Singleton AB
Hum Mol Genet; 2008 Jul; 17(13):1988-93. PubMed ID: 18364387
[TBL] [Abstract][Full Text] [Related]
7. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease.
Strauss KM; Martins LM; Plun-Favreau H; Marx FP; Kautzmann S; Berg D; Gasser T; Wszolek Z; Müller T; Bornemann A; Wolburg H; Downward J; Riess O; Schulz JB; Krüger R
Hum Mol Genet; 2005 Aug; 14(15):2099-111. PubMed ID: 15961413
[TBL] [Abstract][Full Text] [Related]
8. Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria.
Lin CH; Chen ML; Chen GS; Tai CH; Wu RM
Hum Genet; 2011 Dec; 130(6):817-27. PubMed ID: 21701785
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic Role of Serine Protease HtrA2/Omi in Neurodegenerative Diseases.
Goo HG; Rhim H; Kang S
Curr Protein Pept Sci; 2017; 18(7):746-757. PubMed ID: 26965693
[TBL] [Abstract][Full Text] [Related]
10. The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.
Plun-Favreau H; Klupsch K; Moisoi N; Gandhi S; Kjaer S; Frith D; Harvey K; Deas E; Harvey RJ; McDonald N; Wood NW; Martins LM; Downward J
Nat Cell Biol; 2007 Nov; 9(11):1243-52. PubMed ID: 17906618
[TBL] [Abstract][Full Text] [Related]
11. Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1.
Kieper N; Holmström KM; Ciceri D; Fiesel FC; Wolburg H; Ziviani E; Whitworth AJ; Martins LM; Kahle PJ; Krüger R
Exp Cell Res; 2010 Apr; 316(7):1213-24. PubMed ID: 20064504
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial quality control: insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis.
Dagda RK; Chu CT
J Bioenerg Biomembr; 2009 Dec; 41(6):473-9. PubMed ID: 20012177
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of HTRA2/Omi is associated with infantile neurodegeneration and 3-methylglutaconic aciduria.
Mandel H; Saita S; Edvardson S; Jalas C; Shaag A; Goldsher D; Vlodavsky E; Langer T; Elpeleg O
J Med Genet; 2016 Oct; 53(10):690-6. PubMed ID: 27208207
[TBL] [Abstract][Full Text] [Related]
14. HTRA2 variations in Taiwanese Parkinson's disease.
Chen CM; Wu CH; Hsieh CH; Lin CH; Chen IC; Chen YC; Lee LC; Lee CM; Tseng YC; Lee-Chen GJ; Wu YR
J Neural Transm (Vienna); 2014 May; 121(5):491-8. PubMed ID: 24337630
[TBL] [Abstract][Full Text] [Related]
15. What have PINK1 and HtrA2 genes told us about the role of mitochondria in Parkinson's disease?
Plun-Favreau H; Gandhi S; Wood-Kaczmar A; Deas E; Yao Z; Wood NW
Ann N Y Acad Sci; 2008 Dec; 1147():30-6. PubMed ID: 19076428
[TBL] [Abstract][Full Text] [Related]
16. Loss-of-function analysis suggests that Omi/HtrA2 is not an essential component of the PINK1/PARKIN pathway in vivo.
Yun J; Cao JH; Dodson MW; Clark IE; Kapahi P; Chowdhury RB; Guo M
J Neurosci; 2008 Dec; 28(53):14500-10. PubMed ID: 19118185
[TBL] [Abstract][Full Text] [Related]
17. Familial Parkinson's Disease-Associated L166P Mutant DJ-1 is Cleaved by Mitochondrial Serine Protease Omi/HtrA2.
Fu K; Wang Y; Guo D; Wang G; Ren H
Neurosci Bull; 2017 Dec; 33(6):685-694. PubMed ID: 29177768
[TBL] [Abstract][Full Text] [Related]
18. Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson's disease factors Pink1 and Parkin.
Whitworth AJ; Lee JR; Ho VM; Flick R; Chowdhury R; McQuibban GA
Dis Model Mech; 2008; 1(2-3):168-74; discussion 173. PubMed ID: 19048081
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial serine protease HTRA2 gene mutation in Asians with coexistent essential tremor and Parkinson disease.
Chao YX; Ng EY; Foo JN; Liu J; Zhao Y; Tan EK
Neurogenetics; 2015 Jul; 16(3):241-2. PubMed ID: 25791756
[No Abstract] [Full Text] [Related]
20. Akt attenuation of the serine protease activity of HtrA2/Omi through phosphorylation of serine 212.
Yang L; Sun M; Sun XM; Cheng GZ; Nicosia SV; Cheng JQ
J Biol Chem; 2007 Apr; 282(15):10981-7. PubMed ID: 17311912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
